Pricing

Opko Health Inc (OPK)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Phillip Frost
Employees:
4200
4400 BISCAYNE BLVD., MIAMI, FL, 33137
305-575-4181
    Formally known as:
  • CYTOCLONAL PHARMACEUTICS INC
  • eXegenics Inc.
OPKO Health, Inc. engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidi® in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available